Delivery Order SPE2DR25D3301-SPE2DR26F19ED
- Not listed
- The Defense Logistics Agency awarded a $1,349.88 delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs. This is a firm fixed-price, non-set-aside contract with a completion date of December 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol-based medication primarily used for the treatment of seizure disorders, particularly in pediatric...
- The Defense Logistics Agency awarded a $1,682.50 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for Epidiolex 100 mg/ml solution in a 100 ml pack. This non-set-aside competitive award is scheduled for completion by September 10, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Epidiolex is a cannabidiol-based pharmaceutical used primarily for seizure management, reflecting the federal government's medical supply procurement...
- The Defense Logistics Agency awarded a $3,720.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 milliliters of Epidiolex 100 mg/ml solution on November 5, 2025, with completion targeted for November 28, 2025. This is a non-set-aside delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at the company's...
- The Defense Logistics Agency awarded a $8,412.50 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Epidiolex 100 mg/ml solution in 100 ml packs, with completion targeted for September 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs, with a ceiling value of $1,349.88 and an ultimate completion date of December 1, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed from the vendor's location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,523.75 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs on September 12, 2025, with an ultimate completion date of October 3, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,190.00 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. The contract is a firm fixed price delivery order with an ultimate completion date of October 20, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for Epidiolex 100 mg/ml solution in 100 ml packs, valued at $10,095.00 under a firm fixed price arrangement. The delivery order, which is non-set-aside and competitively awarded, has an ultimate completion date of May 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with a ceiling value of $1,280.92 and a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 2, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for Epidiolex 100 mg/ml solution in 100ml packs, with a contract value of $2,659.65 and a completion date of December 1, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement utilizing an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F19EDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,865.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs, with a completion date of December 31, 2025. This non-competitive, firm fixed-price delivery order was issued on December 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol product used primarily for seizure management in specific epilepsy conditions, reflecting the DLA's role in supplying specialized pharmaceutical products to support military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive federal contracting portfolio and competitive capabilities position it as a key supplier within the DLA's pharmaceutical supply chain supporting military readiness and veteran care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 12/8/25 |